Hadas Alterman is a leading legal advocate in the psychedelic industry, with experience advising businesses, investors, and nonprofits navigating the emerging regulated market. She is an advisor to the Texas Ibogaine Initiative, and was instrumental in advancing the recent Executive Order on Accelerating Medical Treatments for Serious Mental Illness to completion to expedite approval pathways for psychedelics. She is also the creator of "Psychedelics & America" an upcoming documentary exploring psychedelics in the United States. Previously, as co-founder of Plant Medicine Law Group LLP, she built the world's first boutique psychedelics law firm to support psychedelic-assisted therapy clinics, retreat centers, training programs, drug development companies, and media organizations. Hadas has played an active role in shaping psychedelic legalization at the state level, as a member of the Oregon Psilocybin Advisory Board for Measure 109 in Oregon, and Natural Medicine Advisory Board for Proposition 112 in Colorado. She was also a Founding Board Member of the Psychedelic Bar Association.